Incidence and survival trends in mantle cell lymphoma
Author:
Affiliation:
1. Medical College of Wisconsin; Milwaukee WI USA
2. University of Alabama at Birmingham; Birmingham AL USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14699/fullpdf
Reference10 articles.
1. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA;Aschebrook-Kilfoy;Leukaemia & Lymphoma,2013
2. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality;Fenske;Journal of Clinical Oncology,2014
3. Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma;Fisher;Journal of Clinical Oncology,2006
4. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group;Geisler;Blood,2008
5. Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study;Goy;Journal of Clinical Oncology,2013
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis;Leukemia & Lymphoma;2024-07-08
2. Mantle Cell Lymphoma Under the Scope of Personalized Medicine: Perspective and Directions;Clinical Lymphoma Myeloma and Leukemia;2024-07
3. Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium;Journal of Hematology & Oncology;2023-12-16
4. Mantle Cell Lymphoma Presenting as Cholecystitis and Nephromegaly;Cureus;2023-12-14
5. SOHO State of the Art Updates and Next Questions: Tailoring Upfront Therapy in Mantle Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3